Evaluation of anticancer role of a novel Ruthenium(II)-based compound compared with NAMI-A and cisplatin in impairing mitochondrial functionality and promoting oxidative stress in triple negative breast cancer models

Publication date: Available online 19 November 2020Source: MitochondrionAuthor(s): Sonia Silvestri, Ilenia Cirilli, Fabio Marcheggiani, Phiwayinkosi Dludla, Giulio Lupidi, Riccardo Pettinari, Fabio Marchetti, Corrado Di Nicola, Giancarlo Falcioni, Cristina Marchini, Patrick Orlando, Luca Tiano, Augusto Amici
Source: Mitochondrion - Category: Biochemistry Source Type: research